Short-Acting Β2-Agonists (SABA) Bronchodilator Sales and Outdoor Mould in Central France

Clinical and Translational Allergy - United Kingdom
doi 10.1186/s13601-019-0296-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Potential Masking Effect on Dyspnoea Perception by Short- And Long-Acting Β2-Agonists in Asthma

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2002English

Effect of Short- And Long-Acting Inhaled Β2-Agonists on Exhaled Nitric Oxide in Asthmatic Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1997English

Unaltered Perception of Dyspnoea During Treatment With Long-Acting Β2-Agonists

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Do Long-Acting Β2-Adrenoceptor Agonists Enhance the Anti-Inflammatory Effect of Glucocorticoids in Asthma?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Interactions of Glucocorticoids and Β2-Agonists

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1996English

Review: Regular Inhaled Long Acting 2 Agonists Are Associated With Better Outcomes Than Short Acting 2 Agonists in Adults and Children With Chronic Asthma

Evidence-based nursing
FundamentalsSkills
2003English

Inhaled Long-Acting Β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Β2-Agonists and Acute Respiratory Distress Syndrome

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2014English

Long-Acting 2-Agonists in Asthma: Safety Concerns

CMAJ
Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy